Pioneers in Neuroscience


Driven by our commitment to patients and our passion for neuroscience, Biogen remains focused on furthering Alzheimer’s disease research and treatment. Visit our resource center for the latest information, news and stories about Alzheimer’s disease at Biogen.

The road to a 100% electric vehicle fleet

Rita Lau Gomes's work routine looks different than it did three years ago, before she had an electric vehicle (EV). Her experience is helping Biogen prepare for a global all-EV fleet.

A message from Alfred Sandrock, EVP Research & Development about ALS investigational therapy
The Alzheimer’s Puzzle: Unlocking the Science 

From imaging that enables us to see amyloid and tau in the brain to determine whether potential therapeutics reach their targets, to one big leap of faith that antibodies can get into the brain, our scientists are not giving up on solving the Alzheimer’s puzzle.

Biogen updates delivered to your inbox
4/12/21 7:00 AM EDT
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
View all news
Diversity, Equity and Inclusion

Biogen is committed to the power of diversity – in our organization and among our patients and customers. Diversity is an essential asset of complementary strengths and perspectives from which all benefit, and which must unite us, not divide us.

Where Science Meets Humanity

Science that transforms patient lives. Science that seeks to solve societal problems. Science that acts with purpose. Science that is inspired by the diversity and passion of our people. Discover where science meets humanity at Biogen.

Follow us on social media